Verrica Pharmaceuticals (VRCA) Finished Goods (2023 - 2025)
Historic Finished Goods for Verrica Pharmaceuticals (VRCA) over the last 3 years, with Q2 2025 value amounting to $991000.0.
- Verrica Pharmaceuticals' Finished Goods rose 1364.68% to $991000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $991000.0, marking a year-over-year increase of 1364.68%. This contributed to the annual value of $717000.0 for FY2024, which is 52347.83% up from last year.
- Latest data reveals that Verrica Pharmaceuticals reported Finished Goods of $991000.0 as of Q2 2025, which was up 1364.68% from $1.2 million recorded in Q1 2025.
- Over the past 5 years, Verrica Pharmaceuticals' Finished Goods peaked at $1.2 million during Q1 2025, and registered a low of $115000.0 during Q4 2023.
- Its 3-year average for Finished Goods is $674875.0, with a median of $699000.0 in 2024.
- As far as peak fluctuations go, Verrica Pharmaceuticals' Finished Goods surged by 52347.83% in 2024, and later surged by 1364.68% in 2025.
- Over the past 3 years, Verrica Pharmaceuticals' Finished Goods (Quarter) stood at $115000.0 in 2023, then soared by 523.48% to $717000.0 in 2024, then surged by 38.21% to $991000.0 in 2025.
- Its last three reported values are $991000.0 in Q2 2025, $1.2 million for Q1 2025, and $717000.0 during Q4 2024.